featured
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial
JAMA Oncol 2020 Dec 30;[EPub Ahead of Print], K Kalinsky, F Hong, CK McCourt, JC Sachdev, EP Mitchell, JA Zwiebel, LA Doyle, LM McShane, S Li, RJ Gray, LV Rubinstein, D Patton, PM Williams, SR Hamilton, BA Conley, PJ O'Dwyer, LN Harris, CL Arteaga, AP Chen, KT FlahertyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.